NCT06021015View on ClinicalTrials.gov

Safety and Efficacy of Polyvinyl Alcohol Sodium Acrylate Embolization Microspheres for CRLM

NANot yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 10, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Colorectal Cancer Liver Metastasis
Interventions
DEVICE

Irinotecan and polyvinyl alcohol sodium acrylate embolization microspheres（Unipearls®）

Irinotecan and polyvinyl alcohol sodium acrylate embolization microspheres（Unipearls®）

DEVICE

Irinotecan and HepaSphere Microspheres

Irinotecan and HepaSphere Microspheres

All Listed Sponsors
lead

Zhongda Hospital

OTHER

NCT06021015 - Safety and Efficacy of Polyvinyl Alcohol Sodium Acrylate Embolization Microspheres for CRLM | Biotech Hunter | Biotech Hunter